AGA
Altrinsic Global Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-41,168
| Closed | -$3.99M | – | 83 |
|
|
2018
Q3 | $3.99M | Sell |
41,168
-15,000
| -27% | -$1.45M | 0.18% | 48 |
|
|
2018
Q2 | $5.29M | Hold |
56,168
| – | – | 0.21% | 48 |
|
|
2018
Q1 | $4.55M | Hold |
56,168
| – | – | 0.18% | 48 |
|
|
2017
Q4 | $5.01M | Buy |
56,168
+11,000
| +24% | +$981K | 0.19% | 49 |
|
|
2017
Q3 | $4.2M | Hold |
45,168
| – | – | 0.16% | 57 |
|
|
2017
Q2 | $4.1M | Hold |
45,168
| – | – | 0.15% | 59 |
|
|
2017
Q1 | $3.97M | Sell |
45,168
-5,000
| -10% | -$439K | 0.13% | 57 |
|
|
2016
Q4 | $4.16M | Sell |
50,168
-20,000
| -29% | -$1.66M | 0.15% | 58 |
|
|
2016
Q3 | $6.49M | Hold |
70,168
| – | – | 0.24% | 51 |
|
|
2016
Q2 | $5.46M | Sell |
70,168
-15,000
| -18% | -$1.17M | 0.15% | 55 |
|
|
2016
Q1 | $7.03M | Hold |
85,168
| – | – | 0.2% | 54 |
|
|
2015
Q4 | $8.92M | Sell |
85,168
-12,000
| -12% | -$1.26M | 0.23% | 53 |
|
|
2015
Q3 | $10.2M | Sell |
97,168
-171,001
| -64% | -$18M | 0.24% | 52 |
|
|
2015
Q2 | $36.7M | Sell |
268,169
-120,057
| -31% | -$16.4M | 0.75% | 44 |
|
|
2015
Q1 | $48.4M | Sell |
388,226
-324,992
| -46% | -$40.5M | 1.05% | 33 |
|
|
2014
Q4 | $64.5M | Sell |
713,218
-930,714
| -57% | -$84.1M | 1.33% | 29 |
|
|
2014
Q3 | $119M | Sell |
1,643,932
-190,054
| -10% | -$13.7M | 2.24% | 19 |
|
|
2014
Q2 | $114M | Buy |
1,833,986
+5,408
| +0.3% | +$336K | 2.01% | 20 |
|
|
2014
Q1 | $125M | Sell |
1,828,578
-250,765
| -12% | -$17.1M | 2.14% | 19 |
|
|
2013
Q4 | $146M | Sell |
2,079,343
-107,839
| -5% | -$7.59M | 2.55% | 18 |
|
|
2013
Q3 | $158M | Sell |
2,187,182
-283,601
| -11% | -$20.5M | 2.69% | 12 |
|
|
2013
Q2 | $138M | Buy |
+2,470,783
| New | +$138M | 2.38% | 19 |
|